NEOGENOMICS INC — Director's Dealing 2017

Aug 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-08-23

Reporting Person: BALLIET JENNIFER (VP and Chief Culture Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-24	Common Stock	M	15000	$3.45	Acquired	15000	Direct
2017-08-24	Common Stock	M	7500	$3.76	Acquired	22500	Direct
2017-08-24	Common Stock	D	22500	$9.38	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-24	Stock Option (Right to Buy)	$3.76	X	7500	Disposed	2018-04-16	Common Stock (7500)	Direct
2017-08-24	Stock Option (Right to Buy)	$3.45	X	15000	Disposed	2019-03-05	Common Stock (15000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (120000)	120000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (50000)	50000	Direct
Stock Option (Right to Buy)	$7.52	2022-04-28	Common Stock (60000)	60000	Direct
Restricted Stock	$0.00		Common Stock (20000)	20000	Direct

Footnotes

F1: Average price of shares sold

F2: On April 16, 2013, Jennifer Balliet was granted 7,500 stock options which vested ratably over the first three anniversary dates of the grant date.

F3: On March 5, 2014, Jennifer Balliet was granted 15,000 stock options which vested ratably over the first three anniversary dates of the grant date.

F4: On May 4, 2015, Jennifer Balliet was granted 120,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F5: On April 20, 2016, Jennifer Balliet was granted 50,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F6: On April 28, 2017, Jennifer Balliet was granted 60,000 stock options. The options vest ratably over the first three anniversaries of the grant date.

F7: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F8: Restricted stock will vest as follows; 6,666 units will vest on May 25, 2018 and 6,667 units will vest on May 25, 2019 and 2020.

F9: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.